The risk associated with aprotinin in cardiac surgery.

To read the commentary by Dean A. Fergusson, MHA, PhD, from the University of Ottawa Centre for Transfusion Research, please click here.

See also the comment by Robert J. Porte, MD, PhD, Department of Surgery, Section Hepatobiliary Surgery and Liver Transplantation, and Herman G.D. Hendriks, MD, PhD, Department of Anesthesiology, University Medical Center Groningen, The Netherlands, on the Nataonline forum.

See also the comment by Dave Royston, MD, FRCA, Consultant in Cardiothoracic Anaesthesia, Department of Anaesthesia and Critical Care, Royal Brompton and Harefield NHS Trust, Harefield, UK, on the Nataonline forum.